Abstract Growth factor receptors are known to be involved in the process of viral infection. Many viruses not only use growth factor receptors to physically attach to the cell surface and internalize, but also divert receptor tyrosine kinase signaling in order to replicate. Thus, repurposing drugs that have initially been developed to target growth factor receptors and their signaling in cancer may prove to be a fast track to effective therapies against emerging new viral infections, including the coronavirus disease 19 (COVID‐19).
All Keywords
【저자키워드】 COVID‐19, SARS‐CoV‐2, heparin, virus, inhibitors, heparan sulfate, Growth factors, tyrosine kinase, cancer drugs, 【초록키워드】 coronavirus disease, viral infection, Cancer, drug, virus, viral infections, COVID‐19, receptor, Signaling, tyrosine, effective therapy, growth factor, Cell, physically, involved, replicate, 【제목키워드】 viral disease, receptor, growth factor, in viral,
【저자키워드】 COVID‐19, SARS‐CoV‐2, heparin, virus, inhibitors, heparan sulfate, Growth factors, tyrosine kinase, cancer drugs, 【초록키워드】 coronavirus disease, viral infection, Cancer, drug, virus, viral infections, COVID‐19, receptor, Signaling, tyrosine, effective therapy, growth factor, Cell, physically, involved, replicate, 【제목키워드】 viral disease, receptor, growth factor, in viral,